Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 296)
Posted On: 11/10/2019 3:22:57 PM
Post# of 154898
Posted By: misiu143
Re: trding #10697
Yes , I don't know also , for a medicine without one serious side effect why 70% efficacy they made a cutoff for mono ,
but they did have 75% with 525 mg many months ago , why not to approve and then ask for more studied/tests with other things and doses ..

This is the only medicine for HIV so far without serious side effects , I know it is very important to FDA , so many things they doing and asking for with Leronlimab I cant understand..

It is very good they made company to look for Receptor Occupancy Test , but it is enough now , lets approve and than continue to improve as with many other drugs..
Why pivotal mono all together at this point....

And , I will never understand why they didn't approve our combo with 81% efficacy with 350 mg , this is for patients who are resistant , sick and many dying..
It could be approve many months ago , everything else could be improve later ..

For long time now , I am not sure if all this may have innocent explanation ,

But as always IMO only.





















(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site